Market Value494,288,000
Total Holdings53
File Date2018-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PTCT / PTC Therapeutics, Inc.
EDIT / Editas Medicine, Inc.
/ Immunomedics, Inc. Call
TSRO / TESARO, Inc.
CNCE / Concert Pharmaceuticals Inc
OBSV / ObsEva SA.
/ Array BioPharma, Inc.
IRTC / iRhythm Technologies, Inc.
GTHX / G1 Therapeutics, Inc.
CELG / Celgene Corp. Call
AVDL / Avadel Pharmaceuticals plc
/ Immunomedics, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
LJPC / La Jolla Pharmaceutical Co.
ABYLY / Ablynx NV
ASMB / Assembly Biosciences, Inc.
FXB / Invesco CurrencyShares British Pound Sterling Trust
ZGNX / Zogenix Inc
JUNO / Juno Therapeutics, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
018490100 / Allergan plc
018490100 / Allergan plc Call
SRPT / Sarepta Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
US64052L1061 / Neos Therapeutics, Inc.
LCI / Lannett Co., Inc.
DRNA / Dicerna Pharmaceuticals Inc
US3723091043 / GenMark Diagnostics, Inc
ANAB / AnaptysBio, Inc.
KDMN / Kadmon Holdings Inc
XLRN / Acceleron Pharma Inc
INFI / Infinity Pharmaceuticals Inc.
AVXS / AveXis, Inc.
CURRENCYSHARES SWISS FRANC T / SWISS FRANC SH (23129V109)
ADMS / Adamas Pharmaceuticals Inc
ECYT / Endocyte, Inc.
KDNY / Chinook Therapeutics Inc
US00C4U1L353 / Mylan N.V.
CPRX / Catalyst Pharmaceuticals, Inc.
INCY / Incyte Corporation
GBT / Global Blood Therapeutics Inc.
NLTX / Neoleukin Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc
DERM / Journey Medical Corporation
CBIO / Crescent Biopharma, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
CLVS / Clovis Oncology Inc
BMY / Bristol-Myers Squibb Company Call
0PP / Portola Pharmaceuticals Inc
KPTI / Karyopharm Therapeutics Inc.
NBRV / Nabriva Therapeutics Plc
BHVN / Biohaven Ltd.
MOTS / Motus GI Holdings, Inc.
TVTX / Travere Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
BHVN / Biohaven Ltd. Call
JNCE / Jounce Therapeutics Inc
CRSP / CRISPR Therapeutics AG
GLYC / GlycoMimetics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
ESPR / Esperion Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
RIGL / Rigel Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
IMGN / ImmunoGen, Inc.
MRTX / Mirati Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc. Put
IOVA / Iovance Biotherapeutics, Inc.
VRAY / ViewRay Inc.
SLDB / Solid Biosciences Inc.
MRSN / Mersana Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
INCY / Incyte Corporation Put
ACAD / ACADIA Pharmaceuticals Inc.
RCKT / Rocket Pharmaceuticals, Inc.
TGTX / TG Therapeutics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
BPMC / Blueprint Medicines Corporation